Instituto de Investigacion Cientifica del Sur

Ponce 00780

0 studies enrolling now · 4 studies all time

What they study most

HIV Infection, HIV-1-infection, Hepatitis C Virus

Studies at this site

• Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Adults Who Are Virologically Suppressed — Completed
• Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir — Completed
• Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment — Completed
• Safety and Efficacy Study of Switching From Epzicom to Truvada — Completed